Air leaks often result in alveolar hypoventilation in mechanically ventilated patients with neuromuscular disease. The primary objective of this study was to assess the feasibility, efficacy and tolerance of a ventilator equipped with an automated air-leak compensation system in a clinical situation. Fourteen neuromuscular patients with nocturnal air leaks during home ventilation were included in a prospective randomised crossover study. A modified VS Ultra ventilator was studied during two consecutive nights and patients were randomly ventilated with and without a leak-compensation system, respectively. Tolerance, minute ventilation, blood gas values, sleep parameters, and nocturnal oxygen saturation were assessed. Leak compensation significantly increased the mean inspiratory and expiratory tidal volumes (731 beneficial effects in neuromuscular patients. The automatic air-leak compensation system tested here should be evaluated in long-term efficacy and tolerance studies and compared to other ventilation modes capable of compensating for leaks, such as pressure support. ª
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Introduction
Long-term home ventilation is an established treatment for neuromuscular patients with respiratory failure, as it improves clinical symptoms, daytime function, arterial blood gas values, sleep quality, 1 quality of life, 2 and survival. 3 No specific recommendations regarding the choice between volume-cycled and pressure-cycled ventilators are made in guidelines about positive-pressure ventilation for patients with chronic respiratory failure. 4 Despite increased interest in the less expensive pressure-cycled ventilators, volume-targeted ventilators remain widely used for non-invasive ventilation (NIV) in patients with neuromuscular disease. 5 Advantages of volume-cycled ventilation may include greater patient comfort and correction of nocturnal and diurnal hypoventilation. 6 In addition, volume-cycled ventilators deliver a constant volume independently from respiratory impedance, and they have better alarm capabilities 7 compared to pressure-cycled ventilators. The main drawback of volume-cycled ventilation is that the set volume is not delivered in the event of air leaks or increased airway resistance. 8, 9 Pressure-cycled ventilators are characterised by greater sensitivity of flow triggering, better patient-ventilator synchronisation, and an ability to compensate for air leaks. 10 However, the use of pressure-targeted modes in patients with neuromuscular diseases remains controversial, because the delivered tidal volume (Vt) varies according to chest-wall compliance and airway resistance. Leak-compensating capabilities may be overwhelmed if the ventilator is unable to maintain inspiratory and expiratory cycling, stay at the targeted pressure, and lengthen the insufflation time. 7, 11 Air leaks may result in persistent hypercapnia 8 and may occur despite adequate adherence to the prescribed mechanical-ventilation regimen. Air leaks are of special concern during REM sleep, 12 when muscle hypotonia increases the risk of alveolar hypoventilation in the event of inadequate ventilator assistance. Minimizing air leaks may be among the best ways to improve the efficiency of assisted ventilation. 13 However, several measures used to avoid leaks are associated with poor tolerance in dependent patients 8, 14, 15 and require frequent arterial blood gas measurements and/or repeated sleep recordings to achieve optimal ventilation. We designed a volume-assured pressure-targeted mode to counterbalance leaks. Volume-assured pressure-targeted modes combine the advantages of pressure-targeted and volume-targeted modes. 16e18 We modified the algorithm of the commercial software to render the inspiratory time and delivered pressure dependent on the patient's expiratory volume, thereby minimizing hypoventilation in the event of leakage. Here, we report preliminary results obtained in a clinical situation with this air-leak compensating system in 14 home-ventilated neuromuscular patients who had nocturnal air leaks.
Methods

Patients
We studied patients who had neuromuscular disease requiring home ventilation and who had nocturnal air leaks identified on the basis of dry mouth or symptoms of nocturnal hypoventilation (e.g., daytime sleepiness or morning headaches) and/or persistent hypercapnia >6.0 kPa despite adequate adherence to the ventilation regimen. Non-inclusion criteria were unwillingness to provide consent to participation in the study, age younger than 18 years, respiratory distress, and need for oxygen therapy.
Ventilator settings
We used the VS Ultra ventilator (SAIME, Savigny le Temple, France), which is a home ventilator capable of volume-and pressure-targeted modes. The VS Ultra ventilator is usually proposed in a single circuit configuration. An optional double limb configuration is also available incorporating an expiratory spirometry. The ventilator was used both in pressure-controlled mode and in a double-circuit configuration. 19 The back-up rate, inspiratory time (Ti), and inspiratory pressure (Ipap) settings were those normally used by the patient at home. Pressure was set at the usual level of Ipap if the patient used a pressure-targeted mode at home. In patients who normally used volume-targeted ventilation, Ipap was set during the day to achieve the same Vt as with the home ventilator. Adjustments were made to obtain a daytime arterial PCO 2 equivalent to the PCO 2 observed with the home ventilator. No Epap was prescribed. The trigger was set at 3 (1 being the most and 6 the least sensitive trigger value).
When the leak-compensation mode is active, the ventilator monitors the patient's expiratory tidal volume (Vte) cycle by cycle, and an algorithm automatically adjusts the ventilator parameters to maintain a minimum level of ventilation. The ventilator continuously calculates the mean of the previous and current Vte value. A security volume (Vts) is set based on the home ventilator parameters: Vts is the set Vt if the usual mode is volume-cycled and the Vt measured by the ventilator if the usual mode is pressure-cycled. When leaks occur, the ventilator tries to maintain Vte at Vts or higher. If Vte falls below Vts, the ventilator automatically increases Ti cycle by cycle, in steps of þ11%, to lengthen the insufflation while keeping the pressure constant, to a maximum of þ33% of the initial Ti (Ti max ). The ventilator stops the increase procedure at the Ti that achieves the Vts. When Vts is not achieved at Ti max , the ventilator then automatically increases Ipap cycle by cycle, in steps of þ1 cm H 2 O, to a maximum of þ5 cm H 2 O (Ipap max ). The ventilator stops the increase procedure at the Ipap value that achieves the Vts. If Vts is still not achieved, the ventilator functions at Ti max and Ipap max . If Vts is achieved, the ventilator returns gradually to the previous settings, as long as Vte remains above Vts. The leak-compensation procedure starts at the first drop in Vte. For this study, we developed a counter that recorded the number of times the air-leak compensation procedure was started.
Study design
We used a prospective randomised crossover design. The study was approved by our institutional review board, and written informed consent was obtained from all patients prior to study inclusion. After the randomisation procedure, the patients were studied during two nights. They used their own interface during both nights. Patients were unaware of the ventilation modes used during the two nights.
Measurements
Full polysomnography was performed using the BRAIN-NET system (Medatec, Brussels, Belgium). Electrophysiological recordings included three electro-encephalogram channels, two electro-oculogram channels, a chin electromyogram, an electrocardiogram (V2 lead), and electromyograms of the right and left tibialis muscles. Inspiratory and expiratory flows were measured using a pneumotachograph (Fleisch #2, Lausanne, Switzerland) situated between the interface and the ventilatory circuit (after the Y piece). Interface pressure was measured using a differential pressure transducer (Validyne MP 45 AE 100 cm H 2 O, Northridge, CA). Abdominal and thoracic movements were recorded using respiratory inductive plethysmography (Respitrace; Ambulatory Monitoring, Ardsley, NY). Gas exchanges were assessed by continuous recording of oxygen saturation (SpO 2 ) (Ohmeda Biox, BOC Healthcare, Boulder, CO) and of transcutaneous carbon dioxide tension (PtCO 2 ) (Radiometer TCM3, Copenhagen, Denmark).
Data analysis
Minute ventilation, Vte and Vti, mean inspiratory and expiratory flow (F inspi and F expi ), Ti, Ttot, Ipap, and respiratory rate (RR) were measured continuously during both nights. Morning arterial blood gas values were measured at the end of each night just before disconnection of the ventilator.
Tolerance was assessed at the end of each night using a 10-cm visual analogue scale (VAS) on which 0 indicated very poor tolerance and 10 very good tolerance. At the end of the study, the patients were asked whether they would like to use the leak-compensation mode.
Sleep data for all patients were read by the same operator (GM), who was blinded to the ventilation mode. Sleep was staged in 30-s periods using Rechtschaffen and Kales criteria. 20 Arousals were evaluated using American Sleep Disorders Association (ASDA) criteria. 21 Time of sleep onset, total sleep period (TSP, time in minutes from sleep onset to final wakening), total sleep time (TST, time in minutes spent sleeping during the TSP), sleep efficiency index (TST/TSP Â 100), number of arousals, percentage of TST spent in each sleep stage (stage 1, stage 2, stages 3e4 or slow-wave-sleep, and rapid-eye-movement sleep [REM]), duration of delta sleep (stages 3 and 4) in minutes, and REM latency were recorded.
Apnoeas and hypopnoeas were scored using inductive plethysmography as previously described. 22 Minimal and mean SaO 2 were measured, as well as the time in minutes and percentage of time spent with SaO 2 < 90%. The difference in peak PtCO 2 between wakefulness and sleep (Delta PtCO 2 ) was calculated.
Statistical analysis
All data are expressed as mean (SD) values. Respiratory and sleep parameters with or without leak compensation were compared using the non-parametric Wilcoxon rank test. Values of p smaller than 0.05 were considered significant.
Results
Patients characteristics
Fourteen patients were randomised. Nocturnal PtCO 2 was recorded in only 10 patients. Mean VC was 1178 AE 493 ml in the seated position and 1049 AE 484 ml in the supine position. Mean Pi max was 40 AE 20 cm H 2 O and mean Pe max was 40 AE 19 cm H 2 O. Of the 14 patients, 13 used a ventilator at home during the night only and one required 24-hour ventilation. All 14 patients complained of nocturnal leaks and five patients had persistent hypercapnia during mechanical ventilation. Patient characteristics are reported in Table 1 . With the home ventilator, mean V T was 665 AE 142 ml, mean RR was 15.5 AE 2.6 breaths/min, and mean Ti was 1.25 AE 0.14 s. Fig. 1 ). Significant increases in F inspi and F expi were noted (Table 2 ). Mean ventilation time was similar in the two study nights (9.1 AE 0.7 vs. 8.9 AE 1.2 h, p Z 0.60).
Arterial blood gas values
Immediately before ventilator disconnection, arterial PCO 2 was significantly lower and pH significantly higher with airleak compensation (Table 2) . No significant effects on alkaline reserve or PO 2 were noted.
Sleep parameters
The VAS scores indicated that tolerance of ventilation was better with the air-leak compensation system ( Table 2) . We found no effects on TST or sleep efficiency. Significant decreases were noted in slow-wave sleep latency and non-significant decreases in stage 1 and REM-sleep latencies. No differences in sleep-stage durations were found, and neither was there any effect on sleep arousal indices or the incidence of hypopnoea/apnoea. With air-leak compensation, the percentage of time spent with SaO 2 <90% tended to be lower, and there was a non-significant increase in delta PtCO 2 . At the end of the study, nine (66%) patients stated that they would like to use the air-leak compensation system at home.
Discussion
In this short-term study conducted in home-ventilated neuromuscular patients who complained of nocturnal air leaks, an automated air-leak compensation system improved minute ventilation, blood gas values, and sleep parameters. Air leaks raise major problems during mechanical ventilation in patients with chronic or acute respiratory failure. 13 In home-ventilated patients, leaks can occur during invasive or non-invasive ventilation. Air leaks are particularly common around nasal masks but occur also with other interfaces such as oronasal masks and uncuffed tracheostomy tubes. 8, 23 Air leaks during the day was reported to decrease the effective Vt by up to 34%; leak severity correlated to PCO 2, and the most common cause of leakage was an inadequate seal between the interface and the patient. 8 During sleep, Vt reduction due to air leaks may have severe adverse effects in neuromuscular patients. 24, 25 Reduced ventilatory assistance in patients with muscle weakness results in patient discomfort, decreases the effectiveness of ventilation, and disrupts patient-ventilato synchronisation and sleep architecture, 8, 26 even in the absence of diurnal hypercapnia. 27 Several strategies have been used to reduce leaks. When leaks occur around a nasal mask, switching to an oronasal mask, 28 using a chinstrap, 8 or taping the mouth 25 may reduce leakage by improving the seal between the patient and the interface. However, these techniques are often difficult to implement and poorly tolerated by patients with advanced neuromuscular disease, who have severe muscle weakness, respiratory failure, swallowing disorders, and difficulty clearing the airway.
14 A tightly applied mask may cause pressure sores. In tracheostomised patients, using a cuffed tube may reduce leaks but also limits phonation and carries a risk of tracheal lesions in the long term. 8, 14 In addition, in the event of ventilator failure, the dependent patient is unable to remove an oronasal mask in order to call for help. 24 Furthermore, methods designed to improve the patient-interface seal are not effective in all patients. 8 Another strategy, which is used empirically, consists in increasing Vt during volume-targeted ventilation, or pressure during pressure-targeted ventilation, in order to increase Vti. This strategy is usually well tolerated and efficient with volume-targeted ventilation 8 but increases upper airway pressure during leak-free periods with pressuretargeted ventilation. 29, 30 Although these methods can reduce the risk of hypoventilation, they fail to eliminate other leak-related complications, such as upper airway dryness, nasal obstruction, and ineffective triggering. 31 On the other hand, we could have used a commercial volumeassured-pressure support, in this study, to achieve a sufficient minute ventilation in case of leaks. These devices increase the Vti especially when working with in a single circuit configuration without monitoring of the expiratory volume. It may expose to inefficient compensation especially when inspiratory leaks are present.
It has been suggested that leaks may induce arousal. However, despite an increase in absolute leak size, we found that increasing air leaks via the compensation system failed to induce arousal. Our air-leak compensation system was well tolerated, although our patients were severely disabled and dependent.
Few studies have sought to determine the optimal mode of ventilation in neuromuscular patients. Pressure-and volume-targeted modes seem to have similar effects on alveolar hypoventilation. 32 Home ventilators vary markedly regarding their ability to compensate for air leaks. Pressure-targeted ventilators have better compensation capabilities than do volume-targeted ventilators, and Vt delivered during leakage is best maintained by pressuretargeted modes. Effectiveness in compensating for air leaks depends on the ability of the ventilator to reach and to maintain a sufficient inspiratory flow rate, and large leaks often overwhelm compensation capabilities. 11 Pressure support 33 compensates for air leaks by increasing Ti, often without appropriate adjustment of inspiration duration, which may lead to excessive insufflation time and to inversion of the inspiration/expiration ratio. 11 We used pressuretargeted ventilation in our study to obtain optimal control of both Ipap and Ti and to determine which of these adjustments was most effective for leak compensation. The studies were done with zero end-expiratory pressure, because the system may overestimate leaks when positive endexpiratory pressure is present; in addition, neuromuscular patients usually have very low levels of intrinsic positive end-expiratory pressure. 34 Our leak-compensation mode shares similarities with pressure-augmentation modes. 35 It more closely resembles volume-targeted ventilation 17 than volume-assured or average-volume-assured pressuresupport modes, which combine the benefits of pressureand volume-targeted ventilation. These modes were first used for brief periods in patients who had acute respiratory failure 16 or were undergoing weaning. 33 Recently, they were used for the long-term treatment of obesity-related hypoventilation syndrome. 18 In these studies, the goal was to adjust for acute changes in ventilatory demand or to improve work of breathing in patients with acute unstable respiratory failure. 17 In our study, in contrast, the goal was to counterbalance the effects of air leaks in patients with chronic stable respiratory failure. Our air-leak compensation system also shares similarities with expert-based knowledge modes, which have been used to automatically assist in weaning by allowing a minimal acceptable level of pressure 36 or, more recently, to maintain alveolar ventilation in patients with acute respiratory failure. 37 The original feature of our leak compensation mode is that a Ti increase is combined with an Ipap increase to maintain sufficient minute ventilation based on monitoring of the patient's Vte. The ventilator takes the amount of leakage into account, cycle by cycle, and increases Vti to obtain a Vte value as close as possible to the set Vts. When the leak compensation program is activated, Vti is increased, first by increasing Ti (by up to 33% if needed) then by increasing Ipap. Significant Ti and Ipap increases occurred in our study, indicating that both adjustments were effective in compensating for leaks and maintaining Vts. Surprisingly, the Ti increase was smaller than expected (13% on average). Thus, the ventilator stopped the Ti increase procedure before the maximal set limit of þ33%, thereby limiting the risk, in clinical situation, of inspiration/expiration inversion and autocycling, by maintaining the Ti/Ttot ratio below 0.5. 11, 31 One important limitation of our system is that expiratory leaks may lead to errors by decreasing the Vte detected by the ventilator. 18 The result may be inappropriately large increases in Ti, inspiratory flow, and Ipap, possibly producing lung overinflation. Excessive pressure level increases due to the leak-compensation system may also increase the size of the leaks and worsen dynamic hyperinflation, as reported in patients with obstructive lung disease. 38 The impact of such hyperinflation is probably more limited in neuromuscular patients. Furthermore, we limited the Ipap increase to a maximum of þ5 cm H 2 O, which probably helped to limit leak increases and drops in mask occlusion pressure, as well as to avoid cycling-off failure 39 and barotrauma. However, the limitations placed on the Ti and Ipap increases for safety reasons also limited the leak-compensation capabilities of the system. Therefore, in the event of large leaks, compensation was only partial, which restricted the ability of the system to more improved sleep and respiratory parameters.
Conclusion
We studied a dual-control mode that targeted a Vte value, in order to compensate for nocturnal air leaks in patients with neuromuscular disease. This mode improved minute ventilation, blood gas values, and several sleep parameters. It was well tolerated despite the presence of severe neuromuscular disease in our patients. It was effective with both invasive and non-invasive ventilation in our shortterm study. Our leak-compensation system is probably less effective in compensating for expiratory leaks than inspiratory leaks and may be ineffective when the entire Vte leaks around the interface. Nevertheless, our results support the feasibility of air-leak compensation and suggest beneficial effects in neuromuscular patients. Our leakcompensation system deserves to be assessed in longterm studies of efficacy and tolerance comparatively to other modes of ventilation capable of leak compensation, such as pressure-support ventilation.
